Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Open accessibility options menu
  • 24/7
  • Buzz
  • Startups
  • VC
  • Finance@
  • Work@
  • Innovation
  • Opinions
  • Search
  • cleanSearch
  • Accesabillty
  • calcalist logo
bycalcalist logo
  • Homepage
  • Tags search
  • Epinephrine

CTech 24/7

  • eToro’s Wall Street honeymoon ends abruptly after first earnings call
  • Hypernative raises $40M Series B to build the security infrastructure Web3 lacks
  • Andreessen Horowitz targets elite IDF alumni for startup accelerator
  • ChatGPT down: Chatbot service suffers major global disruption
More stories in CTech

Epinephrine

1 stories about Epinephrine
  • EpiPen. Photo: AFP

    Teva, Mylan Drop on Announcement of Epinephrine Injector Rival

    09.12.18|Lilach BaumerNovartis’ U.S. division Sandoz announced a planned release for early 2019. The company will sell its drug, which lacks the EpiPen’s auto-injector, for $250 a pair out of pocket, compared to Mylan and Teva’s $300

Load more
Ctech Logo
Twitter
Twitter
Facebook
Facebook
NewsLetter
Newsletter
Contact Us
Contact Us
Rss
Rss
About CTech Terms of Use Privacy Policy
Developed by YIT UI & UX by Basch_Interactive